All In Biotech

Drug Trial Radar · NCT06917404

A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.

A Phase 3, Randomised, Double-Blind, Placebo-Controlled Multi-Centre Study to Evaluate the Treatment Effect of Pentosan Polysulfate Sodium Compared to Placebo in Participants With Knee Osteoarthritis Pain

Last checked: Nov 19, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 466 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

466

Planned (sponsor's estimate)

Start

May 29, 2025

Primary completion

Jul 2027

Study completion Jul 2027

Sponsor

Sponsor type
Industry
First posted
Apr 8, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with subcutaneous injections of placebo in participants with knee OA pain. Study details include: * The study duration will be up to 64 weeks. * The treatment duration will be 6 weeks. * The visit frequency will be twice weekly during treatment. * The visit/contact frequency will be every 4-6 weeks during the 52-week Follow-up period. * Approximately 466 participants will be enrolled into this study.

Conditions

  • Osteoarthritis, Knee

Interventions

  • Pentosan Polysulfate Sodium twice weeklyDrug

    Subcutaneous injection, 2 mg/kg twice weekly for 6 weeks

  • PlaceboDrug

    Placebo, subcutaneous injection, twice weekly for 6 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline at Day 112 in knee pain as assessed by the weekly average of daily pain (ADP) score on the numerical rating scale (NRS) 11-point (0-10) scale.Time frame: Baseline, Daily to Day 112

Locations

57 sites in 4 countries. Site status is shown where the registry gives one.

  • Onyx Clinical Research-Peoria

    Peoria, Arizona

  • Del Sol Research Management, LLC

    Tucson, Arizona

  • Orange County Research Institute

    Anaheim, California

  • Core Healthcare Group

    Cerritos, California

  • Triwest Research Center

    Chula Vista, California

  • Seaside Medical Group

    Oceanside, California

  • Paragon RX Clinical

    Santa Ana, California

  • Encompass Clinical Research

    Spring Valley, California

  • Focus Clinical Research

    West Hills, California

  • Clinical Research of West Florida - Clearwater

    Clearwater, Florida

  • GNP Research

    Cooper City, Florida

  • Arrow Clinical Trials

    Daytona Beach, Florida

  • AGA Clinical Trials

    Hialeah, Florida

  • Evolution Clinical Trials

    Miami, Florida

  • Well Pharma Medical Research

    Miami, Florida

  • K2 Medical Research

    Orlando, Florida

  • Progressive Medical Research

    Port Orange, Florida

  • Phoenix Clinical Research

    Tamarac, Florida

  • Conquest Research

    Winter Park, Florida

  • Chicago Clinical Research, Inc

    Chicago, Illinois

  • Northwestern University

    Chicago, Illinois

  • Sinai Hospital of Baltimore

    Baltimore, Maryland

  • Profound Research

    Farmington Hills, Michigan

  • Insight Research Institute

    Flint, Michigan

  • Rochester Medical Group

    Rochester Hills, Michigan

  • Onyx Clinical Research - Rochester Hills

    Troy, Michigan

  • Physician Research Collaboration

    Lincoln, Nebraska

  • Alpine Healthcare Family Practice

    Las Vegas, Nevada

  • Drug Trials America

    Hartsdale, New York

  • Groth Pain & Spine - Long Island, NY

    Mineola, New York

  • IMA Clinical Research Manhattan

    New York, New York

  • Groth Pain and Spine Management

    Smithtown, New York

  • FutureSearch Trials of Neurology

    Austin, Texas

  • FutureSearch Trials of Dallas

    Dallas, Texas

  • El Paso Clinical Trials

    El Paso, Texas

  • Vilo Research Group

    Houston, Texas

  • DM Clinical Research

    Houston, Texas

  • Clinical Trial Network

    Houston, Texas

  • Epic Clinical Research

    Lewisville, Texas

  • Quality Research Inc.

    San Antonio, Texas

Showing 40 of 57 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.